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Abstract
The peptidoglycan (PG) is a macromolecular component of the bacterial cell wall that maintains the shape and integrity of
the cell. The PG of Caulobacter crescentus, unlike that of many other Gram-negative bacteria, has repeatedly been shown to
contain significant amounts of glycine. This compositional peculiarity has been deemed an intrinsic characteristic of this
species. By performing a comprehensive qualitative and quantitative analysis of the C. crescentus PG by high-performance
liquid chromatography (HPLC) and mass spectrometry (MS), we show here that glycine incorporation into the C. crescentus
PG depends on the presence of exogenous glycine in the growth medium. High levels of glycine were detected at the fifth
position of the peptide side chains of PG isolated from C. crescentus cells grown in the complex laboratory medium PYE or in
defined medium (M2G) supplemented with casamino acids or glycine alone. In contrast, glycine incorporation was
undetectable when cells were grown in M2G medium lacking glycine. Remarkably, glycine incorporation into C. crescentus
peptidoglycan occurred even in the presence of low millimolar to sub-millimolar concentrations of free glycine. High glycine
content in the PG had no obvious effects on growth rates, mode of PG incorporation or cell morphology. Hence, the C.
crescentus PG is able to retain its physiological functions in cell growth and morphogenesis despite significant alterations in
its composition, in what we deem to be unprecedented plasticity.
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Introduction
The peptidoglycan (PG) sacculus, which is a mesh-like
macromolecule situated on the exterior side of the cytoplasmic
membrane, is an essential cellular component of a large variety of
bacterial species. It is composed of glycan chains that are
connected to each other through crosslinks formed between short
peptide side chains [1,2]. Among its many important functions, the
PG is responsible for the maintenance of cellular integrity and for
the conservation of species-specific cellular shapes during growth
and division [3]. Cellular growth and morphogenesis are tightly
connected to the regulated processes of PG synthesis, remodeling
and degradation [1,2,4,5,6]. As a result, genetic or chemical
inactivation of PG synthesizing or modifying enzymes (or of
regulatory factors of these enzymes) can result in growth inhibition
and cell lysis. It is therefore not surprising that many PG inhibitors
(e.g., b-lactam antibiotics and others) have become a widely used
class of antibiotics in medicine. The innate immune system has
also evolved to use PG features as triggers of pathogen recognition
pathways and immune cell activation [7], reflecting the near-
ubiquitous presence of the peptidoglycan throughout the bacterial
kingdom.
Several aspects of PG structure and composition are conserved,
though species-specific differences exist [2]. PG synthesis involves
an intracellular cascade of enzymatic steps, in which a lipid-linked
disaccharide-pentapeptide PG precursor (also known as lipid II) is
synthesized [8,9]. Lipid II is composed of a disaccharide of N-
acetylglucosamine (GlcNAc) and N-acetyl muramic acid (Mur-
NAc), to which the lipid carrier undecaprenyl pyrophosphate and
a pentapeptide with the general sequence L-Ala-D-c-Glu-m-
Dap(Lys)-D-Ala-D-Ala (m-Dap, meso-diaminopimelic acid) are
attached. Lipid II synthesis initiates with the sequential addition
of L-Ala, D-Glu and m-Dap onto UDP-linked MurNAc. The
peptide side chain is completed by the ligation of a D-Ala-D-Ala
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dipeptide. The resulting MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala-D-
Ala moiety is then loaded onto an undecaprenol residue to form
lipid I, to which GlcNAc is added to form lipid II. Next, lipid II is
flipped across the cytoplasmic membrane to its external side,
where it is enzymatically incorporated into the growing PG
macromolecule. Transglycosylases polymerize the lipid II di-
saccharide subunits into PG glycan chains, while transpeptidases
crosslink the peptide side chains between adjacent glycan chains.
Two major types of transpeptidases have been described. D,D-
transpeptidases, which are targets of penicillin and other b-lactam
antibiotics, mediate the substitution of the terminal D-Ala of the
pentapeptide by the side chain of the m-Dap residue of another
peptide, resulting in a D,D- or m-Dap-D-Ala crosslink [10]. L,D-
transpeptidases, on the other hand, mediate the substitution of the
fourth D-Ala residue of one side chain by the m-Dap residue of
a different peptide, resulting in an L,D-, or m-Dap-m-Dap crosslink
Figure 1. Comparison between the PG composition of C. crescentus cells grown in PYE and M2G media. (A). Overlay of HPLC profiles of
muropeptides obtained from C. crescentus cultures grown in PYE (black trace) and M2G (red trace) media. Black arrowheads, Penta(Gly)-containing
muropeptide peaks present only in the PYE-derived sample; red arrowhead, peak corresponding to the PentaTri muropeptide species, identified in
the M2G-derived sample. (B). Relative representation (molar percentage) of each muropeptide species in PG digests obtained from C. crescentus
cultures grown in PYE (black) and M2G (grey) media. Red rectangles denote glycine-containing species. Tri, GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap;
Tetra, GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala; Penta, GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala-D-Ala; Penta(Gly), GlcNAc-MurNAc-L-Ala-D-c-Glu-
m-Dap-D-Ala-Gly; Anh, 1,6-anhydro- MurNAc; (D,D), m-Dap-D-Ala crosslink; (L,D), m-Dap-m-Dap crosslink. Bars represent averages 6 standard
deviation for the three samples analyzed. (C). Summary of the composition of C. crescentus PG digests obtained from cultures grown in the indicated
media. Major PG characteristics are shown, namely the total degree of crosslinkage, the relative amounts of differentially crosslinked muropeptide
classes (monomers, dimers, trimers and tetramers), side chain types (Tri, L-Ala-D-c-Glu-m-Dap; Tetra, L-Ala-D-c-Glu-m-Dap-D-Ala; Penta(Ala), L-Ala-D-c-
Glu-m-Dap-D-Ala-D-Ala; Penta(Gly), L-Ala-D-c-Glu-m-Dap-D-Ala-Gly), or chain ends (anhydro, 1,6-anhydro-MurNAc ). Bars are as in (B). The red rectangle
highlights the relative representation of the Penta(Gly) side chain. (B and C).
doi:10.1371/journal.pone.0057579.g001
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[11]. Together, these enzymatic activities are involved in major
PG biosynthetic processes, which are accompanied by, and likely
coordinated with, a wide array of PG lytic processes [1,4].
Furthermore, numerous proteins without known direct PG
synthesizing or hydrolytic activities are also involved in the
regulation of PG dynamics [6].
The structural and compositional features of the PG presented
above are largely conserved among bacteria [2,12]. Deviations
from this ‘‘canonical’’ model include, but are not limited to: i)
enzymatic modifications of the GlcNAc-MurNAc disaccharide; ii)
amino acid substitutions in positions 1, 2 or 3 of the pentapeptide;
iii) indirect crosslinkage by interpeptide bridges in some Gram-
positive bacteria (i.e. Staphylococcus aureus); and iv) various levels of
representation of the D,D- and L,D- crosslinks [2,12,13]. The
composition of the PG, and especially of the peptide side chains, is
more conserved among Gram-negative bacteria [2,14]. In this
group of organisms, the side chains are derived from the canonical
pentapeptide L-Ala-D-c-Glu-m-Dap-D-Ala-D-Ala, present on the
lipid II PG precursor. During PG growth, several modifications of
the pentapeptide are known to occur, including crosslinking of side
chains by D,D- and L,D-transpeptidases, removal of the terminal D-
Ala by D,D-carboxypeptidases, attachment of Braun’s lipoprotein
by L,D-transpeptidases [15,16,17], and incorporation of non-
canonical D-amino acids (i.e., D-amino acids other than D-Ala or D-
Glu) into the PG [18,19,20].
The crescent-shaped aquatic Gram-negative a-proteobacterium
Caulobacter crescentus has been long thought to synthesize the typical
Gram-negative PG but with some significant differences. For
instance, its PG shows no evidence of a covalent link to Braun’s
lipoprotein, and it contains high amounts of pentapeptide [21,22].
These findings are consistent with the absence of a gene encoding
Braun’s lipoprotein from the C. crescentus genome, and with the
presence of only one D,D-carboxypeptidase-encoding gene [22].
However, the most striking, unexplained feature of the C. crescentus
PG is the high amount of glycine replacing the terminal D-Ala of
the pentapeptide, resulting in the modified peptide side chain L-
Ala-D-c-Glu-m-Dap-D-Ala-Gly or Penta(Gly) instead of the
canonical pentapeptide L-Ala-D-c-Glu-m-Dap-D-Ala-D-Ala, or
Penta(Ala) [21,22]. Penta(Gly) represents roughly half of all
pentapeptide side chains observed in the PG of C. crescentus
[21,22]. The absolute levels of Penta(Gly) side chains in the PG of
C. crescentus range from 11–15% [22,23].
Table 1. Quantification of individual muropeptides identified in the PG of C. crescentus cells grown in PYE or M2G media.
Muropeptide Retention Time (min) Molar Percentage (Mean 6 Standard deviation)
PYE (n = 3) M2G(n = 3)
Tri 20.7 0.4860.19 0.8760.04
Tetra 29.6 21.3260.25 24.0860.20
Penta(Gly) 30.1 3.0560.19 N.D.*
Penta 36.2 14.0560.27 11.8860.03
TetraTri(D,D) 46.5 0.4660.13 0.3960.03
Tri-Anh (+ small amount of TetraTri(D,L)) 47.3 0.3860.08 0.6960.02
TetraPenta(Gly) 49.7 2.7660.08 N.D.*
PentaTri(D,L) 49.8 N.D.* 0.2060.02
TetraTetra 50.9 11.7760.19 15.9560.10
TetraPenta 53.7 10.3160.11 9.0260.18
Tetra-Anh 56.6 1.4460.06 1.3560.04
TetraTetraPenta(Gly) 57.7 0.5760.02 N.D.*
TetraTetraTetra 58.8 2.6760.05 3.6260.01
TetraTetraPenta 60.7 2.3860.11 1.9860.03
TetraTetraTetraTetra 63.0 0.4260.01 0.4960.01
TetraTetraTetraPenta 63.6 0.7660.07 0.6660.01
Penta-Anh 64.4 0.5260.05 0.3460.02
TetraPenta(Gly)-Anh 66.8 & 67.3 0.4860.04 N.D.*
TetraTetra-Anh 68.0 & 68.4 3.9460.18 3.6960.03
TetraPenta-Anh 70.9 & 71.1 2.2560.16 1.3760.03
TetraTetraTetra-Anh 72.0 5.3860.08 7.6460.13
TetraTetraPenta-Anh 73.7 6.0460.15 6.5860.07
TetraTetraTetraPenta(Gly)-Anh 74.2 0.3660.02 0.3460.01
TetraTetraTetraPenta-Anh 74.9 1.8360.20 1.4360.00
TetraTetraTetra-diAnh 83.5 & 84.0 3.4560.02 4.1560.05
TetraTetraTetraPenta-diAnh 84.4 0.9960.01 1.4060.05
TetraTetra-diAnh 85.0 0.9960.01 0.9560.04
TetraTetraPenta-diAnh 85.8 0.9560.00 0.9460.07
Nomenclature of muropeptides as established by Glauner [15]. *N.D. Peak not detected.
doi:10.1371/journal.pone.0057579.t001
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In this study, we perform a comprehensive study of the
composition of PG material isolated from C. crescentus cells grown
in different media. This comparative study demonstrates that
glycine incorporation into the C. crescentus PG is not an intrinsic
property, but is instead the result of the ability of C. crescentus to
incorporate glycine from the environment even when it is present
at low millimolar to sub-millimolar concentrations.
Methods
Growth Conditions
Cultures of the C. crescentus strain CB15N, also known as
NA1000 [24], were grown at 30uC with shaking in the complex
medium PYE (0.2% w/v bacto peptone, 0.1% w/v yeast extract,
1 mM MgSO4, 0.5 mM CaCl2) or in the defined medium M2G
(16M2 salts, 0.5 mM MgSO4, 0.5 mM CaCl2, 10 mM FeSO4,
10 mM EDTA, 0.2% w/v glucose), as previously described [25].
When needed, M2G medium was supplemented with casamino
acids (0.1% w/v final concentration) or glycine (0.2 or 2 mM final
concentration). Growth curves were generated using a Biotek
Synergy2 96 well plate reader. Optical density measurements (at
660 nm) were taken every 2 minutes. Doubling times for each
condition were determined by fitting an exponential curve to the
data within the largest interval representing exponential growth.
Statistics for each condition were calculated from four biological
replicates, each grown in duplicate.
Light Microscopy and Cell Dimensions Analysis
CB15N cultures were grown overnight in the indicated
medium, harvested at an OD below 0.3, and spotted on a 1%
agarose pad containing the indicated medium. Imaging was
performed on a Nikon Eclipse Ti-U equipped with a Hamamatsu
Orca-ER LCD camera. Cell outlines, cell lengths and widths were
determined using Matlab and the open source image analysis
software MicrobeTracker [26].
Muropeptide Analysis
C. crescentus muropeptides were obtained as previously described
[15,22]. Briefly, one-liter cultures of CB15N were grown in the
indicated media to OD660 values between 0.3 and 0.4, cooled on
ice for 10 min, pelleted by centrifugation at 10,4006g and 4uC for
10 min, resuspended in cold M2 salts, and added drop-wise to
boiling 8% SDS solution. The resulting suspension was further
boiled for 30 min with vigorous stirring while water was added to
maintain a relatively constant volume. The resulting peptidoglycan
sacculi were pelleted at 440,0006g for 15 min in a Beckman
Coulter Optima TLX ultracentrifuge and repeatedly washed with
water until free of SDS, as assayed using the Hayashi test [27].
The PG sacculi were next incubated with 100 mg/ml amylase in
10 mM Tris-HCl buffer (pH 7.0) for 2 h at 37uC, and then with
200 mg/ml pronase for 1 h at 60uC (pronase was pre-incubated
for 2 h at 60uC). The enzymes were removed by boiling for
30 min in 4% SDS, and the sacculi were washed free of SDS as
above and stored at 4uC with 0.02% sodium azide in water.
Muropeptides were then obtained by digestion of the sacculi with
20 mg/ml cellosyl in 20 mM sodium phosphate, pH 4.8, overnight
at 37uC. Cellosyl was removed by heating the reaction mixture at
100uC for 10 min, and centrifuging (15,0006g for 30 min). The
muropeptides were reduced with sodium borohydride in 0.25 M
sodium borate, pH 9.0, for 30 min, and the pH of the samples was
adjusted between 3.0 and 4.5 using 20% phosphoric acid. The
samples were then concentrated under vacuum at RT in
a Rotovap, and analyzed by HPLC on an Agilent 1200 system
equipped with a 250 mm by 4.6 mm, 3 mm C18 Prontosil ODS
column maintained at 55uC. The solvent system used was
a 135 min linear gradient from solvent A (50 mM sodium
phosphate, pH 4.31), to solvent B (made by mixing 75 mM
sodium phosphate buffer, pH 4.95 and methanol in a 7:3 volume
ratio). UV absorbance was quantified at 205 nm. Major
muropeptide peak fractions were manually collected and analyzed
by tandem mass spectrometry (MS/MS) as previously described
[28]. Some muropeptides were identified based on their previously
determined retention times and their order of elution [22]. All
calculations were performed as previously described [15,22].
Specifically, for each run, the areas corresponding to all known
peaks were reported as percentages of their sum. Next, these
percentage values were adjusted for different UV absorbance
properties of the various muropeptide species by multiplication
Table 2. Summarized composition of the PG of C. crescentus cells grown in PYE or M2G media.
Peptidoglycan feature Molar percentage (mean 6 standard deviation)
PYE (n = 3) M2G (n = 3)
Monomers 41.2560.71 39.2160.14
Dimers 32.9760.55 31.5660.22
Trimers 21.4360.34 24.9160.16
Tetramers 4.3560.14 4.3260.07
Cross-linkage 34.0460.37 35.6360.07
Pentapeptides (Ala5) 24.8660.23 21.5560.17
Pentapeptides (Gly5) 4.9660.13 0.0960.00
Pentapeptides (Total) 29.8260.18 21.6460.17
Tetrapeptides 69.0960.38 76.5160.16
Tripeptides 1.0960.21 1.8560.05
Anhydro 14.4560.16 15.1460.13
Number of disaccharide subunits (mean 6 standard deviation)
PYE (n = 3) M2G (n = 3)
Average glycan chain length 6.9260.08 6.6160.06
doi:10.1371/journal.pone.0057579.t002
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Figure 2. Comparison between the PG composition of C. crescentus cells grown in unsupplemented and glycine-supplemented M2G
media. (A). Overlay of HPLC profiles of muropeptides obtained from C. crescentus cultures grown in the indicated media. CAA, casamino acids; empty
arrowheads, Penta(Gly)-containing muropeptide peaks; filled arrowheads, peak corresponding to the PentaTri muropeptide species. (B). Relative
representation (molar percentage) of each muropeptide species in PG digests obtained from C. crescentus cultures grown in the indicated media. Red
rectangles denote glycine-containing species; Tri, GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap ; Tetra, GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala; Penta,
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with empirically calculated extinction coefficients [15], and re-
normalized with respect to their sum. The abundance of each
individual class of PG features was also calculated using previously
described formulae [15].
D-cysteine Pulse-chase Experiments
One-liter cultures of CB15N were diluted to an OD660 of
,0.001 in M2G medium and allowed to grow to OD660 ,0.03.
At this time, D-cysteine (D-Cys) was added to the medium at a final
concentration of 125 mg/ml, and the culture was allowed to grow
until the OD660 reached 0.56 (approximately 21 h). The cells were
then collected by centrifugation and split into two samples; one
was used to inoculate a fresh 1 L M2G culture for the chase and
the other was processed immediately. Chase samples were
collected 90, 150, or 210 min after the labeling (OD660 values at
harvest were 0.14–0.26). Purification and biotinylation of the
sacculi were performed as described [29,30]. Immunolabeling,
signal amplification, and electron microscopy were performed as
described [31].
GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala-D-Ala; Penta(Gly), GlcNAc-MurNAc-L-Ala-D-c-Glu-m-Dap-D-Ala-Gly; Anh, 1,6-anhydro- MurNAc; (D,D), m-
Dap-D-Ala crosslink; (L,D), m-Dap-m-Dap crosslink. Bars represent averages 6 standard deviation for two (M2G, M2G + 0.2 mM Gly, M2G + 2 mM Gly)
or three (M2G + 0.1% CAA) samples analyzed. (C). Summary of the composition of C. crescentus PG digests obtained from C. crescentus cultures grown
in the indicated media. Major PG characteristics are shown, namely the total degree of crosslinkage, the relative amounts of differentially crosslinked
muropeptide classes (monomers, dimers, trimers and tetramers), side chain types (Tri, L-Ala-D-c-Glu-m-Dap ; Tetra, L-Ala-D-c-Glu-m-Dap-D-Ala;
Penta(Ala), L-Ala-D-c-Glu-m-Dap-D-Ala-D-Ala; Penta(Gly), L-Ala-D-c-Glu-m-Dap-D-Ala-Gly), or chain ends (anhydro, 1,6-anhydro-MurNAc ). The red
rectangle highlights the relative amounts of the Penta(Gly) side chain. Bars are as in (B).
doi:10.1371/journal.pone.0057579.g002
Table 3. Changes in the muropeptide composition of C. crescentus PG following amino acid supplementation of the defined
growth medium M2G.
Muropeptide Molar Percentage (Mean 6 Standard deviation)
M2G (n=2)
M2G + 0.2 mM Gly
(n =2)
M2G + 0.1% CAA
(n=3)
M2G + 2 mM Gly
(n =2)
Tri 0.6860.02 0.6860.15 0.9760.05 0.6660.01
Tetra 24.9760.07 25.2860.28 29.6860.44 20.3960.23
Penta(Gly) 0.0360.04 0.0560.01 1.2060.06 10.5060.05
Penta 12.4960.31 12.1360.32 10.6160.13 11.2960.44
TetraTri(D,D) 1.2060.08 1.1460.33 3.3161.19 1.2460.21
Tri-Anh (+ small amount of TetraTri(D,L)) 0.5160.00 0.5060.06 0.5660.24 0.3860.25
TetraPenta(Gly) N.D.* N.D.* 2.2060.13 8.9460.58
PentaTri(D,L) 0.2960.01 0.4160.06 N.D.* N.D.*
TetraTetra 15.6760.17 16.2060.79 15.4260.20 10.2960.32
TetraPenta 9.4760.20 9.3360.06 6.3660.10 7.3760.17
Tetra-Anh 1.1660.11 0.9560.08 1.3460.07 0.9760.09
TetraTetraPenta(Gly) 0.0660.02 0.0560.07 0.1660.00 1.6460.24
TetraTetraTetra 3.3260.04 3.4260.13 2.6360.04 1.7960.06
TetraTetraPenta 1.9260.04 1.8860.04 0.9860.07 1.2760.04
TetraTetraTetraTetra 0.4560.03 0.2860.12 0.2260.01 0.1060.14
TetraTetraTetraPenta 0.6060.01 0.6060.10 0.4060.01 0.6060.14
Penta-Anh 0.2860.01 0.2860.01 0.1760.01 0.1960.05
TetraPenta(Gly)-Anh 0.0860.01 0.0360.04 0.3860.06 1.6760.14
TetraTetra-Anh 3.9960.01 4.0760.16 4.2960.10 2.6660.11
TetraPenta-Anh 2.1960.18 2.2160.19 2.4360.31 4.6560.27
TetraTetraTetra-Anh 6.7160.21 6.8160.36 6.0360.12 4.1360.10
TetraTetraPenta-Anh 6.3260.12 6.2660.20 4.4960.13 3.9560.26
TetraTetraTetraPenta(Gly)-Anh 0.3860.03 0.3960.05 0.3160.05 0.4660.37
TetraTetraTetraPenta-Anh 1.5460.31 1.5460.31 0.8360.10 0.8060.30
TetraTetraTetra-diAnh 1.4460.40 1.2460.72 1.5360.07 0.9660.07
TetraTetraTetraPenta-diAnh 1.7260.20 1.7060.15 1.5160.05 1.0860.08
TetraTetra-diAnh 1.7160.10 1.8360.29 1.4760.11 1.3860.37
TetraTetraPenta-diAnh 0.8360.15 0.7360.11 0.5060.05 0.6460.15
*N.D. Not detected.
doi:10.1371/journal.pone.0057579.t003
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Results
Glycine Incorporation into C. crescentus Peptidoglycan is
Growth Medium-dependent
A widely used method to determine the composition and infer
the structure of bacterial PG relies on separation of the sacculi
from other cellular components such as nucleic acids, proteins and
lipids, followed by digestion of the glycan chains with the enzyme
muramidase [15]. Next, the resulting PG fragments, also known as
muropeptides, are reduced, chromatographically separated and
quantified. Their composition and structure can then be analyzed
by chemical or mass spectrometry (MS) techniques [15,28].
Importantly, this sample preparation procedure leaves intact the
peptide side chains found in the analyzed PG, as well as the
crosslinks connecting them. Using these techniques, it has been
shown that C. crescentus PG samples contain high levels of
pentapeptide side chains and that roughly half of them terminated
with a glycine residue [21]. It has therefore been assumed since
then that the PG of C. crescentus is characterized by a high
Penta(Gly) peptide content, an idea supported by later PG analyses
[22,31,32].
However, all published muropeptide analyses have been
conducted on PG isolated from cultures grown in the complex
medium PYE. After performing a control experiment for a cell
wall hydrolase mutant strain [33] that can grow in the defined
medium M2G but not in PYE, we became suspicious that the PG
composition may be sensitive to the composition of the growth
medium (data not shown). Therefore, we performed a thorough
comparative analysis of PG from wild-type CB15N cultures grown
in either PYE or M2G (n= 3 for each). As expected, we identified
both free and crosslinked forms of Penta(Gly)-containing mur-
opeptides in the samples we obtained from PYE-grown cultures
(Fig. 1A, black trace and arrowheads, Fig. 1B, red rectangles, and
Table 1). In contrast, these glycine-containing muropeptides were
virtually undetectable in samples obtained from M2G-grown
cultures (Fig. 1A, red trace, Fig. 1B, and Table 1). Penta(Gly)
peptides represented 4.9660.13% of all side chains and 17% of all
pentapeptides within the PG of PYE-grown cells (Fig. 1C and
Table 2). Their presence represented the major difference between
the muropeptide profiles of C. crescentus PG obtained from PYE
and M2G cultures.
There were other discernible differences. For example, the
relatively abundant TetraPenta(Gly) dimer present among the
muropeptides isolated from PYE-grown cells (retention time
49.7 min, Fig. 1A and Table 1) was replaced in the M2G-grown
sample by a significantly smaller peak with a similar retention time
(49.9 min, Fig. 1A, red arrowhead). We identified the muropep-
tide from this peak as the (L,D)-crosslinked PentaTri dimer, which
was likely masked in the chromatogram of the PYE-based sample
by the more abundant TetraPenta(Gly) dimer. We also observed
overall higher amounts of pentapeptides (,30% vs. ,22%) and
lower amounts of tetrapeptides (,69% vs. ,77%) in the PG of
PYE-grown cells compared to that of M2G-grown cells (Fig. 1C
and Table 2). Tetrapeptide side chains may form as a result of two
enzymatic pathways: either D,D-carboxypeptidase-mediated re-
moval of the terminal D-Ala of the pentapeptide, or transpepti-
dase-mediated crosslinkage (D,D-transpeptidation) of two side
chains followed by cleavage of the crosslink by an endopeptidase.
The apparent inversely correlated differences between the levels of
these two types of side chains in the PG of PYE- and M2G-grown
samples could be explained by the presence of the Penta(Gly)
species, if this peptide functions as a less efficient substrate for
either the D,D-carboxypeptidase or the transpeptidases of C.
crescentus. These differences were, however, not associated with
major effects on the degree of PG crosslinkage or on the average
length of the glycan chains (Fig. 1C and Table 2). This result
suggests that the C. crescentus PG is tolerant to some changes in its
composition.
Addition of Glycine to M2G Medium Results in its
Incorporation into the PG
Our finding that the Penta(Gly) side chain was present in the
PG of C. crescentus cells grown in the complex medium PYE but not
in the minimal medium M2G suggested that the incorporation of
glycine may depend on the presence of this amino acid in the
growth medium. Furthermore, three studies of C. crescentus PG
Table 4. Summary of changes in the composition of C. crescentus PG following amino-acid supplementation of the defined
growth medium M2G.
Peptidoglycan feature Molar Percentage (Mean 6 Standard deviation)
M2G
(n=2)
M2G + 0.2 mM Gly
(n =2)
M2G + 0.1% CAA
(n=3)
M2G + 2 mM Gly
(n=2)
Monomers 40.1060.34 39.8860.58 44.5460.39 44.3860.33
Dimers 34.5960.22 35.2161.30 35.8560.34 38.1960.22
Trimers 20.6060.10 20.3960.28 16.3360.31 14.3860.09
Tetramers 4.7060.46 4.5260.44 3.2860.20 3.0460.01
Cross-linkage 34.5660.30 34.5960.14 31.2760.28 30.9760.18
Pentapeptides (Ala5) 22.7360.22 22.3160.62 17.8560.36 20.0660.25
Pentapeptides (Gly5) 0.1860.03 0.1860.07 2.6360.11 16.4760.29
Pentapeptides (Total) 22.9160.19 22.4960.55 20.4760.47 36.5260.04
Tetrapeptides 75.1660.16 75.5660.33 76.3360.18 61.8160.41
Tripeptides 1.9360.03 1.9560.22 3.1960.32 1.6660.37
Anhydro 13.9960.17 13.7360.34 12.9960.65 12.0260.11
Disaccharide subunits/glycan chain (mean 6 standard deviation)
Glycan chain length 7.1560.09 7.2960.18 7.7160.39 8.3260.08
doi:10.1371/journal.pone.0057579.t004
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composition identified different values for the Penta(Gly) levels in
the PG of PYE-grown cultures:,11%, as calculated from the data
reported in a 1983 study [21] and for cultures grown in
unsupplemented PYE [22], ,15%, for cultures grown in PYE
supplemented with 20 mM Tris-HCl buffer pH 8.0 [22], and
,5% for the PYE-grown samples analyzed in this study. As the
sources of nutrients in PYE medium are enzymatic digests of
animal tissue (peptone) and yeast [25], we expect batch-to-batch
variations in the concentrations of the different components of this
complex medium, including glycine. Based on an analysis of
commercially available peptone and yeast extract [34], we
calculated that PYE medium made with Difco nutrients contains
approximately 4.6 mM total glycine, including 0.3 mM free
glycine. The M2G medium formulation, on the other hand, does
not include any amino acids [25]. We thus hypothesized that
addition of relatively small amounts of exogenous glycine to the
otherwise glycine-free growth medium M2G would cause in-
corporation of this amino acid into the C. crescentus PG. Consistent
with this hypothesis, growing cells in M2G medium supplemented
with 2 mM glycine was sufficient to generate high levels of glycine
incorporation into the PG, as visualized and quantified from
HPLC traces (Fig. 2A and 2B, Table 3). The Penta(Gly) side
chains represented 16.560.3 % of all the side chains and 45% of
all pentapeptides in these samples (Fig. 2C and Table 4). Other
differences in C. crescentus PG composition that were observed
following growth in glycine-supplemented M2G medium were
small. Namely there were slight decreases in the degree of
crosslinkage and in the amounts of trimers, tetramers, and
tetrapeptides, while monomer and dimer levels and the average
Table 5. Cell dimensions and growth rates of C. crescentus in various growth media.
Growth medium
Estimated Gly conc.
(mM)
Cell width (mm)
(Mean 6 SD)
Cell length (mm)
(Mean 6 SD)
Doubling time (min)
(Mean 6 SD)
PYE 4.6 0.7260.02 2.8860.67 10461
M2G 0 0.7060.03 2.7960.64 12062
M2G + 0.2 mM Gly 0.2 0.7160.02 2.7960.64 11963
M2G + 0.1% CAA 0.16 0.7160.03 2.7160.60 11362
M2G + 2 mM Gly 2 0.7160.02 2.8860.71 12463
doi:10.1371/journal.pone.0057579.t005
Figure 3. D-cysteine labeling of PG sacculi. Transmission electron micrographs of D-Cys-labeled sacculi either before (top) or after (bottom) a 90-
min chase period. These sacculi were obtained from cells grown in M2G medium. D-Cys residues were biotinylated and visualized by silver
enhancement of nanogold-coupled anti-rabbit secondary antibody bound to anti-biotin primary antibody. Sacculi were counterstained with uranyl
acetate. Dashed lines indicate areas of label clearing. PHB, polyhydroxybutyrate granules.
doi:10.1371/journal.pone.0057579.g003
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length of the glycan chains were only mildly increased (Fig. 2C and
Table 4).
We were also able to identify the Penta(Gly) peaks when we
grew the cells in M2G medium supplemented with 0.1% casamino
acids (CAA), which represent a more complex source of amino
acids (Fig. 2A). In this case, the Penta(Gly) levels were low but
detectable, consisting of 2.6360.11% of all side chains and 13% of
all pentapeptides (Fig. 2B and 2C, Tables 3 and 4). A CAA
concentration of 0.1% is estimated to yield 0.16 mM free glycine
[35]. When we supplemented M2G medium with a concentration
of glycine (0.2 mM) similar to that in M2G + 0.1% CAA medium,
we failed to detect significant amounts of Penta(Gly) muropeptides
(Fig. 2A, 2B and 2C; Tables 3 and 4). It is possible that the
availability of other amino acids in the CAA solution enhances the
incorporation of Gly in the PG (see Discussion). In any case, our
results indicate that growth of C. crescentus in media containing low
concentrations of glycine is sufficient to cause incorporation of this
amino acid into the PG in the form of a Penta(Gly) peptide side
chain.
Because addition of high levels (0.05% or higher) of glycine to
the PYE medium (resulting in ,11 mM total glycine) have been
shown to cause morphological abnormalities of C. crescentus cells,
growth delays, and even cell lysis [23,36], we tested whether the
low levels (up to 2 mM) of glycine that we used in our experiments
also affected the growth rate or morphology of C. crescentus cells
(Table 5). We found no effect on cell length or width, and growth
rates were not substantially affected by addition of 0.2 or 2 mM
glycine to M2G medium. Addition of 0.1% casamino acids caused
an increase in the growth rate, likely due to the casamino acids
acting as an additional nutrient source.
New PG Incorporation Occurs at Midcell during Growth
in Defined M2G Medium
In C. crescentus, FtsZ-dependent preseptal PG growth contributes
significantly to cell elongation [29]. This conclusion was in part
based on pulse-chase D-cysteine (D-Cys) labeling experiments on
cells grown in PYE medium. Given the differences between the
composition of PG isolated from cells grown in PYE and M2G
media, it became important to test whether preseptal PG growth
also occurred in cells grown in M2G media, which do not
incorporate Gly into the PG. Therefore, we performed D-Cys
pulse-chase labeling experiments in M2G cultures. Repeating
these experiments with M2G cultures turned out to be challeng-
ing, as the incorporation of D-Cys was considerably less efficient in
M2G than in PYE (data not shown). However, we were able to
obtain sufficient labeling of PG sacculi of wild-type cells after
growth in M2G with 125 mg/ml D-Cys (Fig. 3). By chasing labeled
cells for 90 min in the absence of D-Cys, we observed midcell
clearing of the D-Cys label in sacculi with little or no midcell
constriction (Fig. 3), consistent with preseptal growth occurring in
the M2G medium, and similar to what is observed in cells grown
in PYE [29]. Thus, preseptal PG elongation is not correlated with
glycine incorporation and is a general mode of growth in C.
crescentus. This notion is supported by the observation that MurG,
the enzyme that produces the PG precursor lipid II, is recruited
early to the FtsZ ring in non-constricting cells in M2G medium
[29,37].
Discussion
Early studies [21] suggested that high levels of glycine
incorporation into the C. crescentus PG (as a Penta(Gly) side
peptide) is a general characteristic of this bacterium. Our results
indicate that this is unlikely. We show that the PG of C. crescentus
cells grown in amino acid-free M2G medium contains very low
levels of Penta(Gly) side chains, if any. Rather, efficient in-
corporation of glycine into the C. crescentus PG requires its presence
in the growth medium at concentrations in the sub-millimolar to
low millimolar range, as found in the complex medium PYE or
when exogenously added to the amino acid-free medium M2G.
Since the 1983 C. crescentus study, Penta(Gly) side chains have
been identified in the PG of other species, although we note that in
every case, cultures were grown in complex media. From
published muropeptide analysis of PG from other species, we
calculate Penta(Gly) levels of ,7% in S. aureus [38], 0.4% in E. coli
[16] and ,5% [39,40] or ,10% [41] in Helicobacter pylori.
Penta(Gly) side chains were also identified in the PG of
Staphylococcus haemolyticus [42] and of Neisseria gonorrhoeae [43], but
their relative abundance was not quantified. Based on our findings,
we suspect that the glycine in the PG of these various bacteria is
not an intrinsic feature and is medium-specific. In agreement with
this idea, supplementing complex media with very high concen-
trations (50 mM to 1.33 M) of glycine results in Penta(Gly) side
chain formation in various bacterial species [38,44].
How are the Penta(Gly) side chains synthesized? Interestingly,
non-canonical D-amino acids produced by a plethora of bacterial
species [19,20] have been shown to replace D-Ala at the fifth
position of the pentapeptide [18]. Specifically in the case of C.
crescentus, growth in PYE medium supplemented with 2 mM D-
Met results in its incorporation into the PG as Penta(D-Met) at
levels representing ,10% of all muropeptides [18]. Incorporation
of D-amino acids into pentapeptides occurs during an early
cytoplasmic step of PG precursor synthesis, specifically during the
formation of the D-Ala-D-Ala dipeptide by D-Ala-D-Ala ligases
(Ddls) [18]. Non-canonical D-amino acids replace the second D-
Ala residue of the dipeptide, and are thereby introduced into the
PG precursor pathway [18]. It is likely that glycine incorporation
also occurs at this step, resulting in the formation of a D-Ala-Gly
peptide which is then utilized by downstream biosynthetic
enzymes, resulting in the formation of a modified lipid II PG
precursor. Indeed, glycine’s achiral center may formally be viewed
as either a ‘‘D’’ form or an ‘‘L’’ form, and thus could serve as
a substrate for a promiscuous Ddl. Supporting this hypothesis,
several purified Ddls have been shown to be able to use glycine as
substrate in in vitro assays, albeit with lower affinity than the normal
substrate D-Ala [45]. Furthermore, the E. coli MurF enzyme,
which catalyzes the addition of the D-Ala-D-Ala peptide onto
MurNAc-L-Ala-D-c-Glu-m-Dap during the cytoplasmic steps of
PG precursor synthesis, has been shown to be able to use the D-
Ala-Gly peptide as a substrate [46]. Thus, while we cannot exclude
other mechanisms, we suggest that, in the presence of sub-
millimolar to low millimolar concentrations of free glycine in the
growth medium, the C. crescentus Ddl synthesizes a mix of D-Ala-D-
Ala and D-Ala-Gly peptides, which are then added to MurNAc-L-
Ala-D-c-Glu-m-Dap by MurF, helping to create a pool of
Penta(Gly)-containing PG precursors that are incorporated into
the PG in downstream biosynthetic steps.
Our study reveals that in C. crescentus, very low (down to sub-
millimolar) concentrations of glycine in the medium yield high
levels (up to ,15% of all side chains) of glycine incorporation in
the PG; PYE and 0.01% CAA solutions are estimated to contain
only 0.3 and 0.16 mM of free glycine. In contrast, the PG of E. coli
cells grown in LB or PB media, which contain estimated 0.9 mM
of free glycine, display Penta(Gly) levels below 0.5% [16].
Similarly, the PG of Bacillus subtilis cells grown in LB or nutrient
broth (0.9 mM free glycine) has levels of Penta(Gly) either
undetectable or below 3%, respectively [47]. The PG of both E.
coli and B. subtilis have low overall levels of pentapeptides because
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of D,D-carboxypeptidase activity. However, deletion of the B.
subtilis dacA gene, which encodes a D,D-carboxypeptidase, results
in a dramatic (,40-fold) increase in Penta(Ala) that is accompa-
nied by only a comparatively mild (,2.7-fold) increase in
Penta(Gly) [47]. Thus, C. crescentus appears more efficient (or less
intolerant) at incorporating glycine into its PG. We note that
higher glycine concentrations are needed to drive glycine in-
corporation into the PG of C. crescentus when this amino acid is
added alone (M2G + 2 mM glycine) than when it is added as part
of a more complex amino acid mixture (PYE or M2G + 0.1%
CAA condition). This may reflect competition between glycine
incorporation into the PG and its utilization in catabolism and
other amino acid synthetic pathways; such competition might be
relieved if other amino acids and nutrients are provided in
complex media.
C. crescentus cells grown in M2G medium must also contain
glycine in their cytoplasm as they produce it for protein synthesis;
yet they do not incorporate it into the PG. Perhaps the glycine
concentration in the cytoplasm of M2G-grown cells is too low to
be used by the Ddl enzyme but high enough for the protein
synthesis machinery.
The physiological significance of glycine incorporation into C.
crescentus PG remains elusive. The natural habitats of Caulobacter
species, mostly aquatic environments [48,49], are poor in
nutrients, and are therefore unlikely to contain concentrations of
glycine sufficient for PG incorporation. However, glycine in-
corporation into the PG robustly occurs during growth in the
widely used laboratory medium PYE. We note that very high (10–
100 mM) concentrations of glycine in laboratory growth media
are detrimental to C. crescentus, as they lead to morphological
alterations, decreased growth rates, and cell lysis [36]. Similar
phenotypic effects have been observed when other bacterial
species are grown in the presence of high concentrations (50 mM
to 1.33 M) of glycine [44]. These phenotypes may be due to
inhibition of the periplasmic transpeptidation reactions, leading to
a lower degree of crosslinkage between glycan strands and thus
reducing the integrity of the PG mesh and its resistance to osmotic
pressure. Indeed, lower levels of PG crosslinkage were observed
when C. crescentus and several other bacteria were grown in media
supplemented with high concentrations of glycine [23,44]. Under
our conditions of low glycine concentration in the media, the
degree of PG crosslinkage is only minimally affected, if at all
(Fig. 1C and 2C, Tables 2 and 4), despite the significant
accumulation of Penta(Gly) side chains in the PG. The pattern
of PG growth (i.e., pre-septal elongation of new PG material
around the midcell) also appears unaffected by the change in the
PG (and presumably Lipid II precursor) composition (Fig. 3). This
apparent plasticity in the behavior of C. crescentus may be important
for growth in biofilm communities [50], where local concentra-
tions of nutrients, including glycine, may reach substantial levels
due to release from dying cells.
Acknowledgments
The authors thank the members of the Jacobs-Wagner laboratory for
helpful discussions, and Joe Gray from the PINNACLE facility, Newcastle
University, for MS analysis of muropeptides.
Author Contributions
Conceived and designed the experiments: CNT MTC SP WV CJW.
Performed the experiments: CNT JH MTC NKB SP. Analyzed the data:
CNT JH SP WV CJW. Contributed reagents/materials/analysis tools:
WV. Wrote the paper: CNT CJW.
References
1. Ho¨ltje JV (1998) Growth of the stress-bearing and shape-maintaining murein
sacculus of Escherichia coli. Microbiol Mol Biol Rev 62: 181–203.
2. Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and
architecture. FEMS Microbiol Rev 32: 149–167.
3. Young KD (2006) The selective value of bacterial shape. Microbiol Mol Biol
Rev 70: 660–703.
4. Vollmer W, Joris B, Charlier P, Foster S (2008) Bacterial peptidoglycan (murein)
hydrolases. FEMS Microbiol Rev 32: 259–286.
5. Vollmer W, Bertsche U (2008) Murein (peptidoglycan) structure, architecture
and biosynthesis in Escherichia coli. Biochim Biophys Acta 1778: 1714–1734.
6. Typas A, Banzhaf M, Gross CA, Vollmer W (2012) From the regulation of
peptidoglycan synthesis to bacterial growth and morphology. Nat Rev Microbiol
10: 123–136.
7. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999)
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-
like receptor 2. J Biol Chem 274: 17406–17409.
8. Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, et al. (2008) Cytoplasmic
steps of peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 168–207.
9. Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D (2008) The
biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol Rev
32: 208–233.
10. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P (2008) The penicillin-
binding proteins: structure and role in peptidoglycan biosynthesis. FEMS
Microbiol Rev 32: 234–258.
11. Magnet S, Dubost L, Marie A, Arthur M, Gutmann L (2008) Identification of
the L,D-transpeptidases for peptidoglycan cross-linking in Escherichia coli.
J Bacteriol 190: 4782–4785.
12. Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and
their taxonomic implications. Bacteriol Rev 36: 407–477.
13. Vollmer W (2008) Structural variation in the glycan strands of bacterial
peptidoglycan. FEMS Microbiol Rev 32: 287–306.
14. Quintela JC, Caparros M, de Pedro MA (1995) Variability of peptidoglycan
structural parameters in Gram-negative bacteria. FEMS Microbiol Lett 125: 95–
100.
15. Glauner B (1988) Separation and quantification of muropeptides with high-
performance liquid chromatography. Anal Biochem 172: 451–464.
16. Glauner B, Ho¨ltje JV, Schwarz U (1988) The composition of the murein of
Escherichia coli. J Biol Chem 263: 10088–10095.
17. Magnet S, Bellais S, Dubost L, Fourgeaud M, Mainardi JL, et al. (2007)
Identification of the L,D-transpeptidases responsible for attachment of the Braun
lipoprotein to Escherichia coli peptidoglycan. J Bacteriol 189: 3927–3931.
18. Cava F, de Pedro MA, Lam H, Davis BM, Waldor MK (2011) Distinct pathways
for modification of the bacterial cell wall by non-canonical D-amino acids.
EMBO J 30: 3442–3453.
19. Lam H, Oh DC, Cava F, Takacs CN, Clardy J, et al. (2009) D-amino acids
govern stationary phase cell wall remodeling in bacteria. Science 325: 1552–
1555.
20. Cava F, Lam H, de Pedro MA, Waldor MK (2011) Emerging knowledge of
regulatory roles of D-amino acids in bacteria. Cell Mol Life Sci 68: 817–831.
21. Markiewicz Z, Glauner B, Schwarz U (1983) Murein structure and lack of DD-
and LD-carboxypeptidase activities in Caulobacter crescentus. J Bacteriol 156: 649–
655.
22. Takacs CN, Poggio S, Charbon G, Pucheault M, Vollmer W, et al. (2010) MreB
drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the
cell wall. J Bacteriol 192: 1671–1684.
23. Markiewicz Z, Kraus W (1985) Composition of Caulobacter crescentus murein
synthesized in the presence of glycine. FEMS Microbiol Lett 29: 1–4.
24. Evinger M, Agabian N (1977) Envelope-associated nucleoid from Caulobacter
crescentus stalked and swarmer cells. J Bacteriol 132: 294–301.
25. Ely B (1991) Genetics of Caulobacter crescentus. Methods Enzymol 204: 372–384.
26. Sliusarenko O, Heinritz J, Emonet T, Jacobs-Wagner C (2011) High-
throughput, subpixel precision analysis of bacterial morphogenesis and
intracellular spatio-temporal dynamics. Mol Microbiol 80: 612–627.
27. Hayashi K (1975) A rapid determination of sodium dodecyl sulfate with
methylene blue. Anal Biochem 67: 503–506.
28. Bui NK, Gray J, Schwarz H, Schumann P, Blanot D, et al. (2009) The
peptidoglycan sacculus ofMyxococcus xanthus has unusual structural features and is
degraded during glycerol-induced myxospore development. J Bacteriol 191:
494–505.
29. Aaron M, Charbon G, Lam H, Schwarz H, Vollmer W, et al. (2007) The
tubulin homologue FtsZ contributes to cell elongation by guiding cell wall
precursor synthesis in Caulobacter crescentus. Mol Microbiol 64: 938–952.
30. de Pedro MA, Quintela JC, Ho¨ltje JV, Schwarz H (1997) Murein segregation in
Escherichia coli. J Bacteriol 179: 2823–2834.
31. Cabeen MT, Charbon G, Vollmer W, Born P, Ausmees N, et al. (2009)
Bacterial cell curvature through mechanical control of cell growth. EMBO J 28:
1208–1219.
Glycine Incorporation in Caulobacter Peptidoglycan
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e57579
32. Cabeen MT, Murolo MA, Briegel A, Bui NK, Vollmer W, et al. (2010)
Mutations in the lipopolysaccharide biosynthesis pathway interfere with
crescentin-mediated cell curvature in Caulobacter crescentus. J Bacteriol 192:
3368–3378.
33. Poggio S, Takacs CN, Vollmer W, Jacobs-Wagner C (2010) A protein critical for
cell constriction in the Gram-negative bacterium Caulobacter crescentus localizes at
the division site through its peptidoglycan-binding LysM domains. Mol
Microbiol 77: 74–89.
34. BD (2006) BD BionutrientsTM Technical Manual. Advanced Bioprocessing.
Revised 3rd ed. 1–68.
35. Nolan RA (1971) Amino acids and growth factors in vitamin-free casamino
acids. Mycologia 63: 1231–1234.
36. Markiewicz Z, Kwiatkowski Z (1985) Autolysis of Caulobacter crescentus grown in
the presence of glycine. Acta Microbiol Pol 34: 5–14.
37. Hocking J, Priyadarshini R, Takacs CN, Costa T, Dye NA, et al. (2012)
Osmolality-dependent relocation of penicillin-binding protein PBP2 to the
division site in Caulobacter crescentus. J Bacteriol 194: 3116–3127.
38. de Jonge BL, Chang YS, Xu N, Gage D (1996) Effect of exogenous glycine on
peptidoglycan composition and resistance in a methicillin-resistant Staphylococcus
aureus strain. Antimicrob Agents Chemother 40: 1498–1503.
39. Sycuro LK, Pincus Z, Gutierrez KD, Biboy J, Stern CA, et al. (2010)
Peptidoglycan crosslinking relaxation promotes Helicobacter pylori’s helical shape
and stomach colonization. Cell 141: 822–833.
40. Sycuro LK, Wyckoff TJ, Biboy J, Born P, Pincus Z, et al. (2012) Multiple
peptidoglycan modification networks modulate Helicobacter pylori’s cell shape,
motility, and colonization potential. PLoS Pathog 8: e1002603.
41. Costa K, Bacher G, Allmaier G, Dominguez-Bello MG, Engstrand L, et al.
(1999) The morphological transition of Helicobacter pylori cells from spiral to
coccoid is preceded by a substantial modification of the cell wall. J Bacteriol 181:
3710–3715.
42. Billot-Klein D, Gutmann L, Bryant D, Bell D, Van Heijenoort J, et al. (1996)
Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing
increasing levels of resistance to glycopeptide antibiotics. J Bacteriol 178: 4696–
4703.
43. Martin SA, Rosenthal RS, Biemann K (1987) Fast atom bombardment mass
spectrometry and tandem mass spectrometry of biologically active peptidoglycan
monomers from Neisseria gonorrhoeae. J Biol Chem 262: 7514–7522.
44. Hammes W, Schleifer KH, Kandler O (1973) Mode of action of glycine on the
biosynthesis of peptidoglycan. J Bacteriol 116: 1029–1053.
45. Sato M, Kirimura K, Kino K (2005) D-Amino acid dipeptide production
utilizing D-alanine-D-alanine ligases with novel substrate specificity. J Biosci
Bioeng 99: 623–628.
46. Duncan K, van Heijenoort J, Walsh CT (1990) Purification and characterization
of the D-alanyl-D-alanine-adding enzyme from Escherichia coli. Biochemistry 29:
2379–2386.
47. Atrih A, Bacher G, Allmaier G, Williamson MP, Foster SJ (1999) Analysis of
peptidoglycan structure from vegetative cells of Bacillus subtilis 168 and role of
PBP 5 in peptidoglycan maturation. J Bacteriol 181: 3956–3966.
48. Poindexter JS (1964) Biological properties and classification of the Caulobacter
group. Bacteriol Rev 28: 231–295.
49. Poindexter JS (1981) The caulobacters: ubiquitous unusual bacteria. Microbiol
Rev 45: 123–179.
50. Entcheva-Dimitrov P, Spormann AM (2004) Dynamics and control of biofilms
of the oligotrophic bacterium Caulobacter crescentus. J Bacteriol 186: 8254–8266.
Glycine Incorporation in Caulobacter Peptidoglycan
PLOS ONE | www.plosone.org 11 February 2013 | Volume 8 | Issue 2 | e57579
